Literature DB >> 22807165

FDA approves first drug to prevent HIV infection.

Bob Roehr.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22807165     DOI: 10.1136/bmj.e4879

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  17 in total

1.  Perceived Versus Calculated HIV Risk: Implications for Pre-exposure Prophylaxis Uptake in a Randomized Trial of Men Who Have Sex With Men.

Authors:  Jill Blumenthal; Sonia Jain; Evan Mulvihill; Shelly Sun; Marvin Hanashiro; Eric Ellorin; Sara Graber; Richard Haubrich; Sheldon Morris
Journal:  J Acquir Immune Defic Syndr       Date:  2019-02-01       Impact factor: 3.731

2.  GSK1265744 demonstrates robust in vitro activity against various clades of HIV-1.

Authors:  Sharon L Karmon; Hiroshi Mohri; William Spreen; Martin Markowitz
Journal:  J Acquir Immune Defic Syndr       Date:  2015-03-01       Impact factor: 3.731

Review 3.  Should we fear resistance from tenofovir/emtricitabine preexposure prophylaxis?

Authors:  Urvi M Parikh; John W Mellors
Journal:  Curr Opin HIV AIDS       Date:  2016-01       Impact factor: 4.283

4.  Medical Mistrust and PrEP Perceptions Among Transgender Women: A Cluster Analysis.

Authors:  Paul A D'Avanzo; Sarah Bauerle Bass; Jesse Brajuha; Luis Gutierrez-Mock; Nicole Ventriglia; Carine Wellington; Jae Sevelius
Journal:  Behav Med       Date:  2019 Apr-Jun       Impact factor: 3.879

Review 5.  Pre-exposure prophylaxis for sexually-acquired HIV risk management: a review.

Authors:  James Wilton; Heather Senn; Malika Sharma; Darrell Hs Tan
Journal:  HIV AIDS (Auckl)       Date:  2015-04-28

6.  Topical Delivery of Tenofovir Disoproxil Fumarate and Emtricitabine from Pod-Intravaginal Rings Protects Macaques from Multiple SHIV Exposures.

Authors:  Priya Srinivasan; John A Moss; Manjula Gunawardana; Scott A Churchman; Flora Yang; Chuong T Dinh; James M Mitchell; Jining Zhang; Rob Fanter; Christine S Miller; Irina Butkyavichene; Janet M McNicholl; Thomas J Smith; Marc M Baum; James M Smith
Journal:  PLoS One       Date:  2016-06-08       Impact factor: 3.240

7.  PrEP Interest Among Men Who Have Sex with Men in the Netherlands: Covariates and Differences Across Samples.

Authors:  Mart van Dijk; Sascha B Duken; Rosemary M Delabre; Richard Stranz; Vincent Schlegel; Daniela Rojas Castro; Adeline Bernier; Paul Zantkuijl; Robert A C Ruiter; John B F de Wit; Kai J Jonas
Journal:  Arch Sex Behav       Date:  2020-03-02

8.  The pre-exposure prophylaxis (PrEP) consciousness of black college women and the perceived hesitancy of public health institutions to curtail HIV in black women.

Authors:  Rasheeta Chandler; Shawnika Hull; Henry Ross; Dominique Guillaume; Sudeshna Paul; Nikita Dera; Natalie Hernandez
Journal:  BMC Public Health       Date:  2020-07-28       Impact factor: 3.295

9.  Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.

Authors:  Patrick Owuor Mbullo; Lisa Ruth Hirschhorn; Maya Jackson-Gibson; Ashley Uzoamaka Ezema; Wicklife Orero; Irene Were; Ramael Osasogie Ohiomoba
Journal:  BMC Public Health       Date:  2021-07-01       Impact factor: 3.295

10.  Use of an HIV-risk screening tool to identify optimal candidates for PrEP scale-up among men who have sex with men in Toronto, Canada: disconnect between objective and subjective HIV risk.

Authors:  James Wilton; Taylor Kain; Shawn Fowler; Trevor A Hart; Troy Grennan; John Maxwell; Darrell Hs Tan
Journal:  J Int AIDS Soc       Date:  2016-06-03       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.